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Abstract
Lineage conversion of one somatic cell type into another constitutes an attractive approach for 
research and clinical use. Lineage conversion can proceed in a direct manner, in the absence of 
proliferation and multipotent progenitor generation, or in an indirect manner, by the generation of 
expandable multipotent progenitor states. Here we report on the development of a combined 
reprogramming methodology that, transitioning through a plastic intermediate state, allows for the 
generation of human mesodermal progenitor cells while circumventing the traditional hallmarks of 
pluripotency. Converted mesodermal progenitor cells demonstrated bi-potent differentiation 
potential and were able to generate endothelial and smooth muscle lineages. Importantly, human 
fibroblasts can be converted into angioblast-like progenitor cells by non-integrative approaches. 
Differentiated angioblast-like cells exhibit neo-angiogenesis and anastomosis in vivo. The 
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methodology for indirect lineage conversion to angioblast-like cells described here adds to the 
armamentarium of reprogramming approaches aimed at the clinical treatment of ischemic 
pathologies.
INTRODUCTION
Somatic cell reprogramming has highlighted the high plasticity of adult somatic cells as well 
as the possibility of generating any desired cell type in unlimited amounts. Based on the 
forced expression of selected transcription factors (TFs), three major different approaches 
allowing for somatic cell reprogramming have recently been described1. First, somatic cells 
can be reprogrammed into induced Pluripotent Stem Cells (iPSCs), embryonic-like cells 
with the potential, upon further differentiation, to generate all different cell-types present in 
the adult organism2. Second, the concept of TFs defining or specifying target cell identity 
has proven successful for the direct lineage conversion of mouse and human cells into a 
number of different cell types3–6. Finally, the fact that reprogramming leading to iPSC 
formation proceeds in a step-wise de-differentiation manner suggests that this process can be 
controlled and stopped prior to the acquisition of an embryonic-like signature. Indeed, 
coupling a partially de-differentiated plastic state to specific differentiation conditions has 
demonstrated a feasible alternative way to generate murine cardiac and neuronal cells7–11.
In here we present the development of a simple and highly efficient method allowing for the 
conversion of human fibroblasts into CD34+ progenitor cells with bi-potent differentiation 
potential. The process of conversion occurs indirectly by shortening and/or bypassing 
complete reprogramming to pluripotency while allowing for the generation of a “plastic” 
state. Transitioning through a plastic intermediate state allowed for re-differentiation into 
CD34+ progenitor cells and subsequently, further differentiation to functional endothelial 
and smooth muscle lineages.
RESULTS
Development of an Angioblast-like differentiation media
We speculated that coupling a robust differentiation protocol to partially reprogrammed cells 
could provide a suitable platform for cell fate conversion. As such, we developed a robust 
media suitable for the differentiation of pluripotent stem cells (PSCs) to mesodermal 
progenitor cells prior to establishing the reprogramming conditions necessary for cell-fate 
conversion. Thus, we systematically analyzed different well-known mediators of 
mesodermal development in different human PSC (hPSC) lines12. We found that a media, 
hereafter referred to as Mesodermal Induction Media or MIM, containing DMEM:F12, 15 
mg ml−1 stem cell grade BSA, 17.5 μg ml−1 Human Insulin, 275 μg ml−1 Human holo-
transferrin, 20 ng ml−1 bFGF, 50 ng ml−1 Human VEGF, 25 ng ml−1 human BMP4, 450 μM 
monothioglycerol and 2.25 mM L-Glutamine and Non-essential amino acids, but in the 
absence of Activin-A, was highly efficient in driving hPSCs to a mesodermal fate (Fig. 1a 
and Supplementary Fig. 1). Next, we tested MIM differentiation on multiple human PSC 
lines by focusing on CD34 expression, an early marker for mesoderm-derived progenitor 
cells with hematopoietic and/or endothelial and smooth muscle differentiation potential (Fig. 
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1b–f and Supplementary Fig. 1–2). A peak of CD34+ cells was observed by day 8 in every 
analyzed cell line. In parallel, we observed upregulation of the vascular marker CD31 (Fig. 
1b–f and Supplementary Fig. 1–2) accompanied by rapid downregulation of pluripotency-
related markers (Fig. 1g and Supplementary Fig. 2). Similarly, expression of mesodermal 
progenitor markers was significantly upregulated (Fig. 1b–g and Supplementary Fig. 1–2). 
Additionally, we observed the upregulation of several early markers related to 
hematopoiesis, including RUNX1 and SCL/TAL1 (Supplementary Fig. 2). Thus, MIM might 
lead to the generation of a tri-potent hemangioblast-like state with hematopoietic, 
endothelial and smooth muscle differentiation potential. MIM-differentiated PSC-derived 
CD34+ cells (PSCCD34+) did not result in the expression of any hematopoietic marker 
analyzed at the protein level or the formation of hematopoietic colonies in standard 
hematopoietic Colony Forming Assays.
We next wondered whether MIM-induced CD34+ cells represented a developmental stage 
similar to that of angioblast cells13 by investigating the potential of PSCCD34+ cells to 
differentiate into endothelial and smooth muscle lineages. Sorting of 8 days MIM- 
differentiated PSCCD34+ cells and subsequent differentiation towards the endothelial lineage 
gave rise to endoglin and VE-cadherin positive endothelial cells (Fig. 1h and Supplementary 
Fig. 3). Importantly, expression of von Willebrand factor (vWF), a mature endothelial 
marker and pro-coagulant protein additionally playing a role in wound healing and vessel 
repair, was readily detected (Fig. 1h and Supplementary Fig. 3). Two-step differentiation of 
PSCs by inducing mesoderm commitment and subsequent differentiation of CD34+ cells 
towards the endothelial lineage, gave rise to 60–90% VE-cadherin+ endoglin+ cells in all 
cell lines analyzed. qPCR analysis of PSC-differentiated endothelial cells demonstrated 
significant upregulation of endothelial markers whereas no upregulation was observed for 
smooth muscle markers (Fig. 1i and Supplementary Fig. 3); thus, indicating specificity of 
differentiation towards the endothelial lineage.
Similarly, PSCCD34+ cells were sorted and subjected to smooth muscle differentiation 
conditions. Differentiation of isolated progenitors yielded a high number of smooth muscle 
cells (Supplementary Fig. 4). mRNA analysis demonstrated significant upregulation of 
smooth muscle markers, including expression of the smooth muscle-specific high molecular 
weight Caldesmon type 1 (CALD1), while no endothelial marker was upregulated 
(Supplementary Fig. 4). Single cell differentiation assays demonstrated the multipotent 
nature of the generated cells (Supplementary Fig. 4). Next, we performed genome-wide 
DNA methylation and gene expression studies. As expected there was a clear distinction 
between all of the differentiated samples and the undifferentiated PSCs at both, the 
transcriptome as well as the methylome level (Fig. 1j, k and Supplementary Fig. 5). Few 
unique differences between PSC-endothelial differentiated cells and primary endothelial 
cells were found. Similarly, there was a clear distinction between all of the differentiated 
smooth muscle samples as compared to undifferentiated PSCs (Supplementary Fig. 6).
In summary, our studies identify a novel chemically defined media (MIM) leading to the 
generation of CD34+ progenitor cells in a more efficient manner than previously described 
protocols14–16. MIM differentiation was sufficient for the generation of PSCCD34+ cells 
with the potential to generate both endothelial and smooth muscle lineages. Thus, MIM 
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differentiation of PSCs results in the generation of a progenitor population resembling an 
angioblast-like state.
Conversion of human fibroblasts to Angioblast-like cells
We next asked whether MIM could suffice for the conversion of human fibroblasts into 
CD34+ angioblast-like progenitor cells (FibCD34+). Thus, we decided to couple a first phase 
of “plastic” induction or de-differentiation by short-term exposure to iPSC reprogramming 
conditions7,8, followed by MIM differentiation (Fig. 2a). First, we explored the suitability of 
this conversion process by retroviral approaches and the traditional four-factor combination, 
including SOX2, Oct4, KLF4 and c-Myc, in two different lines of neonatal (HFF and BJ) as 
well as adult human dermal fibroblasts (HDF). 8-day exposure of human fibroblasts to 
reprogramming factors and iPSC-like culture conditions coupled to MIM differentiation for 
an additional 8-day period led to the appearance of a prominent FibCD34+ population (Fig. 
2b, c). Additionally, we asked whether the miR 302–367 clusters, demonstrated to play a 
role during reprogramming towards iPSCs17,18, could lead to increasing efficiencies 
of FibCD34+ cell generation. miR 302–367 seemed to contribute to the conversion of human 
fibroblasts in some but not all lines analyzed (Fig. 2c and Supplementary Fig. 7). MIM 
differentiation led to a significant upregulation of angioblast-related markers in all 
conditions analyzed (Fig. 2d). Sorting of MIM-differentiated FibCD34+ cells and subsequent 
differentiation into endothelial and smooth muscle cells resulted in the upregulation of 
lineage-specific markers at both the RNA and protein levels (Fig. 2e, f and Supplementary 
Fig. 7). We next sought to determine the minimal combination of factor(s) required for the 
conversion of human fibroblasts into FibCD34+ by systematic single factor removal. 
Marginal levels of CD34+ cells were found when SOX2 was employed alone. Yet, 
subsequent differentiation of sorted SOX2-generated CD34+ cells did not result in the 
generation of endothelial nor smooth muscle cells. Altogether, the four Yamanaka factors, 
alongside the use of iPSC-like culture conditions, seemed indispensable for the conversion, 
into FibCD34+ with bi-potent differentiation potential resembling that of an angioblast-like 
state.
Similarly to PSC differentiation, cell fate conversion of human fibroblasts towards the 
endothelial lineage resulted in a mixture of different endothelial sub-types, including the 
expression of arterial, venous and lymphatic endothelial markers19 (Supplementary Fig. 8). 
Along the same line, analysis of human fibroblasts converted to smooth muscle cell 
populations demonstrated mixed expression of smooth muscle markers20 including 
expression of the pericyte marker NG2 (Supplementary Fig. 9). Of relevance, the converted 
endothelial cells had lost many features of the fibroblast profile and acquired characteristics 
of primary endothelial cells (Fig. 2g and Supplementary Fig. 5). Converted endothelial cells 
also lost their fibroblast epigenetic signature and acquired a DNA methylation profile that 
closely resembled that of primary endothelial cells (Fig. 2h and Supplementary Fig. 5). 
When all samples were compared, regardless of their method of derivation, fibroblasts 
formed a third major group in the differentiated portion of the dendograms, slightly closer to 
the primary and PSC-differentiated endothelial cell clusters as compared to converted 
endothelial cells, which clustered more closely to iPSC-differentiated cells. Interestingly, 
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both, the mRNA expression and DNA methylation results were very similar in terms of 
describing the relationships among all different cell types (Supplementary Fig. 5 and 6).
Altogether, our results demonstrate that 8-day exposure to iPSC reprogramming factors and 
culture conditions was sufficient for the induction of an intermediate plastic state in human 
fibroblasts. Further mesodermal induction by 8-day exposure to MIM yielded intermediate 
CD34+ bi-potent progenitor populations, which ultimately led to the generation of both 
endothelial and smooth muscle cell populations. Whereas expandable populations, alongside 
the lack of clonal expansion and colony formation, made precise frequency analysis 
technically difficult,“angioblast conversion efficiencies” could be calculated by estimating 
the ratio between the final number of converted cells and the initial number of fibroblasts. 
Taking into account that 75,000 fibroblasts give rise to ~2×106 cells by the end of MIM 
commitment, of which 20–60% are CD34+ (depending on the cell line of origin and the 
method used for plasticity induction), conversion efficiencies would range between 400–
1200%. Altogether, human fibroblasts were subjected to three different steps during the 
process of conversion: first, a controlled phase of reprogramming totaling 8 days; second, 
specification of the generated reprogrammed intermediates to mesodermal FibCD34+ 
progenitor cells by MIM; lastly, further differentiation of the generated FibCD34+ cells to 
endothelial and smooth muscle cells.
Conversion to angioblasts by non-integrative approaches
We next wondered whether the process of conversion could result in an iPSC-like stage 
even in the absence of visible flattened ES-like colonies. We focused on TRA1-81 and 
TRA1-60 expression as the latter has been recently described as the most reliable early 
marker for iPSC generation, with a success prediction rate of up to 90%21. Plastic induction 
did not lead to the expression of either TRA1-60 or TRA1-81 (Fig. 2b and Supplementary 
Fig. 10).
Noticeably, residual expression of the transgenes was still detectable upon differentiation 
(Supplementary Fig. 10). In view of these results as well as the possibility for re-activation 
of integrated oncogenes, we next pursued the establishment of non-integrative approaches. 
To this end we evaluated an episomal vector combination proven to allow for the generation 
of human iPSCs in the presence of murine feeder layers22. A six-factor combination 
including Oct4, SOX2, KLF4 and non-transforming LMYC (MYCL1) alongside shRNA-p53 
and LIN28 was chosen for further experiments (Fig. 3). Plastic reprogramming intermediates 
were obtained by electroporation of 1.5 μg of DNA from each of the vectors followed by a 
6-day resting phase prior to switching to iPSC-like reprogramming conditions (Fig. 3a). 
After 8 days, the media was changed to MIM, for an additional 8 days resulting, in the 
appearance of CD34+ cells whereas expression of TRA1-60 and TRA1-81 remained 
undetectable (Fig. 3b, c). Sorting of FibCD34+ cells and subsequent differentiation into 
endothelial and smooth muscle lineages resulted in the upregulation of cell-type specific 
markers at both the RNA and protein level (Fig. 3d–g). The generated endothelial and 
smooth muscle cells represented mixed populations of different sub-types similar to the 
results obtained by differentiation of PSCs (Fig. 3g).
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Most importantly, we observed the rapid clearing of the episomal vectors and no random 
integration of exogenous genes was detected in the differentiated endothelial cells 
(Supplementary Fig. 10). Furthermore, testis injection of one million differentiated 
endothelial cells did not result in teratoma formation in any of the groups analyzed after 10 
weeks, including cells generated by differentiation of PSCs (Supplementary Fig. 10).
Converted cells are functional in vitro and in vivo
Two well-characterized physiological hallmarks of smooth muscle cell function are their 
calcium responses as well as cell contraction capabilities20,23,24. Contraction of 
differentiated smooth muscle cells occurred both spontaneously as well as upon drug 
stimulation (Supplementary Fig. 11 and Supplementary Video 1). Exposure to carbachol 
resulted in rapid Calcium transients. Of note, whereas we did observe a response of 293T 
human embryonic kidney cells to carbachol, this response was limited to calcium transients 
and did not result in the physical contraction of the cells as demonstrated by their unchanged 
cell surface area (Supplementary Fig. 11). We next investigated the functionality of the 
generated endothelial cells by measuring their acetylated-LDL uptake, a characteristic of 
mature endothelial cells. CD34+-derived endothelial cells showed significantly higher rates 
of LDL uptake as compared to their respective negative controls (Fig. 3h and Supplementary 
Fig. 12). Noticeably, differentiated endothelial cells aggregated into vessel-like structures in 
vitro and were able to form functional vessels, allowing for blood circulation, after 17 days 
in vivo (Fig. 3i, 4 and Supplementary Fig. 12). Thus, demonstrating connection of the newly 
formed vessels to the pre-existing vasculature. Endothelial cell identity was verified by 
Ulex-lectin binding and the human origin of the cells further verified by in situ hybridization 
(Fig. 4b, c) as well as the use of antibodies specific for human CD31 and co-localization 
with the human nuclear antigen (Fig. 4d, e).
Altogether our results demonstrate that the use of chemically defined MIM media allowed 
for the commitment of plastic reprogramming intermediates to an angioblast-like fate. 
Further differentiation of angioblast-like cells resulted in the generation of functional 
endothelial and smooth muscle cells. Most importantly, 8-day reprogramming coupled to 
subsequent MIM differentiation for another 8 days was sufficient to drive the conversion of 
both neonatal and adult human fibroblasts to angioblast-like progenitor cells while 
bypassing iPSC generation. Lastly, PSC-derived as well as converted CD34+-derived 
endothelial cells demonstrated functionality in vitro and contributed to the vasculature in 
vivo.
DISCUSSION
We have established an efficient method for the conversion of human fibroblasts into 
CD34+ angioblast-like progenitor cells (Supplementary Table 1). These cells could be 
further differentiated into functional endothelial and smooth muscle cells. Interestingly, we 
observed certain differences at both the transcriptome and methylome level when compared 
to the positive controls. One possible explanation could reside in the unspecific nature of the 
generated endothelial and smooth muscle populations, including different sub-types of each 
respective major lineage as compared to the primary cells analyzed (Human Umbilical Vein 
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Endothelial Cells and Arterial Smooth Muscle Cells). Another explanation could be 
reminescent to the epi/genetic differences found when comparing iPSCs versus ESCs, their 
respective positive “control”, as well as when comparing different ESC clones25. Lastly, 
residual epigenetic marks from the initial fibroblast cells might also account for the observed 
differences6. Nevertheless, all the cells generated (either differentiated from PSCs or derived 
by conversion of human fibroblasts) demonstrated functional properties, thus, highlighting 
the potential of these novel conversion methodologies as well as the importance of analyzing 
functional parameters in reprogramming paradigms6,25,26.
Conversion into angioblast-like progenitor cells occurred in the absence of iPSC colony 
formation, surface marker expression and re-activation of the endogenous transcription 
network regulating pluripotency, therefore shortening considerably the time required for 
generation of the desired cell types. Whereas the current measures do not permit us to rule 
out that converted cells transitioned through a somewhat “pluripotent-like” state, the lack of 
pluripotent marker expression and teratoma formation indicates that the conversion process 
does not result in the typical iPSC features. Furthermore, the fact that induction of 
“plasticity” relies on a first phase of epigenetic erasure, which by similarity with iPSC 
reprogramming might imply a stochastic process, strongly suggests that the heterogeneity 
observed at the molecular level during the conversion process might be due to the presence 
of cells with varying degrees of epigenomic plasticity. The present study represents the first 
demonstration that short-term induction by iPSC reprogramming conditions, followed by 
exposure to a chemically defined differentiation media, is sufficient for the conversion of 
neonatal and adult human fibroblasts into angioblast-like progenitor cells. Of note, not only 
the autonomous effects of the reprogramming factors but the overall combination of stem 
cell culture conditions promoting cell proliferation, as exemplified by the requirement of 
bFGF, have demonstrated to be crucial during the process of conversion in a similar way to 
iPSC reprogramming. Interestingly, culture conditions have also been highlighted as a 
critical component during the conversion process in similar reports7,8. Contrary to direct 
lineage conversion, that requires precise knowledge and screening of molecules defining 
target cell identity, induction of “plastic/de-differentiation” states coupled to specific 
differentiation protocols might provide a general, more readily accessible, platform towards 
the broader generation of clinically relevant cell types. Furthermore, whereas direct lineage 
conversion might be viewed as an “unnatural” process6 occurring in the absence of 
progenitor cell generation, our results and those reported for the murine system7,8 show, as 
during normal embryogenesis, the formation of intermediate progenitor states. Therefore, 
whereas direct lineage conversion occurs in one-to-one basics in the absence of progenitor 
cell generation and cell proliferation, transition through a proliferative progenitor state may 
have two major practical implications. On the one hand the generation of progenitor cells 
with multilineage differentiation capacity strongly diversifies the spectra of applications as 
opposed to direct lineage conversion. On the other hand, the inability to generate 
proliferative populations by direct lineage conversion could represent a major limitation for 
applications in which large numbers of cells are required6,9. Of note, in the case shown here, 
the conversion of human fibroblasts into vascular smooth muscle and endothelial cells 
proceeds through the generation of an expandable population of vascular progenitors with 
multilineage differentiation capacity. Altogether, our results describe a novel methodology 
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for the reprogramming of somatic cells and provide a complementary approach to those of 
direct lineage conversion and iPSCs methodologies for the generation of specific human cell 
types.
MATERIAL AND METHODS
Reagents and antibodies
The following antibodies were used at the specified concentrations: mouse anti-human 
CD34-APC 1:10 (130–046–703, Miltenyi), mouse anti-human CD133/2 (293C3)-PE 1:10 
(130–090–853, Miltenyi), mouse anti-human CD144-PE 1:10 (VE-cadherin; 560410, BD 
biosciences), mouse anti-human CD144-APC 1:10 (VE-cadherin; 348507, Biolegend), 
CD105-PE 1:10 (endoglin; ab60902, Abcam), mouse anti-human CD105-PE 1:10 (endoglin; 
560839, BD biosciences), CD31-FITC 1:10 (555445, BD biosciences), CD117-PeCy7 1:10 
(c-Kit; 339195, BD biosciences), VEGFR2-PE 1:10 (KDR; 560494, BD biosciences), 
mouse anti-human CD45-FITC 1:10 (130–080–202, Miltenyi), anti-human CD235a-PE 1:10 
(340947, BD biosciences), mouse APC isotype control 1:10 (555751, BD biosciences), 
mouse FITC isotype control 1:10 (555748, BD biosciences), PeCy7 isotype control 1:10 
(557872, BD biosciences), PE isotype control 1:10 (555749, BD biosciences), VE-Cadherin 
1:500 (555661, BD biosciences), Endoglin 1:500 (M3527, DAKO), Anti-von Willebrand 
Factor 1:200 (vWF; 7356, Millipore), calponin 1:500 (Dako, M3556), α-SMA 1:500 
(AB56994, Abcam), α-SMA 1:1000 (A5228, Sigma), PECAM-1 (M-20) 1:100 (CD31; 
sc1506, Santa Cruz Biotechnology) anti-Human Nuclei 1:100 (MAB1281, Millipore), DAPI 
[5 mg ml−1] 1:2000 (D1306, Invitrogen), Hoechst 33342 [5mg ml−1] 1:2000 (B2261, 
Sigma), Alexa fluor 488 goat anti-mouse (A11001, Invitrogen), Alexa fluor 488 Donkey 
anti-goat (A11055, Invitrogen), Alexa fluor 568 Donkey anti-mouse (A10037, Invitrogen), 
Alexa-fluor 568 Donkey anti-rabbit (A10042, Invitrogen).
Cell culture
Human ES cells, H1 (WA1, WiCell), HuES 9 (http://www.mcb.harvard.edu/melton/hues/) 
and Human iPS cells CBiPS27 and KiPS28 (KIPS 4F#2, CBiPS 2F#4) (passage 25–45) were 
cultured in chemically defined hES/hiPS growth media (mTeSR29 on growth factor reduced 
matrigel (35623, BD biosciences) coated plates). Briefly, 70–80% confluent hES/iPS cells 
were treated with dispase (Invitrogen) for 7 minutes at 37°C, colonies were dispersed to 
small clusters and lifted carefully using a 5 ml glass pipette, at a ratio of ~1:4. Neonatal 
human fibroblasts (HFF-1, BJ; ATCC) and adult human dermal fibroblasts (HDF-693) were 
cultured in DMEM containing 10% FBS, 2 mM GlutaMAX (Invitrogen), 50 U ml−1 
penicillin and 50 mg ml−1 streptomycin (Invitrogen). Human Umbilical Vein Endothelial 
Cells (HUVEC) were purchased from Promocell and cultured in EBM medium 
supplemented with EGM-2 singlequots (cc-3162, Lonza), 2% FBS, hEGF 10 μg ml−1, 
Heparin 100 μg ml−1 (Sigma). iPS/ES-derived endothelial cells were cultivated in EBM-2 
medium supplemented with EGM-2 singleQuot kit (cc-3162, Lonza). iPS/ES-derived 
smooth muscle cells were cultured in SmBM medium supplemented with SmGM-2 
singleQuot kit (cc-3182, Lonza). All the cells were grown in collagen I coated plates (BD 
biosciences). All cell lines were maintained in an incubator (37°C, 5% CO2) with media 
changes every day (hES/iPS) or every second day (HUVEC/Fibroblasts).
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Directed differentiation of hES/hiPS cells in chemically defined conditions
Human ES/iPS cells cultured as described above were freshly split on matrigel-coated 
plates, making sure the sub-colonies were of small size (~300–500 cells/colony). After 24 
hours of recovery in mTeSR, the cells were gently washed using DMEM:F12 (Invitrogen) 
and allowed to grow in chemically defined differentiation media (Mesodermal Induction 
Media or MIM), which consists of DMEM:F12, 15 mg ml−1 stem cell grade BSA (MP 
biomedicals), 17.5 μg ml−1 Human Insulin (SAFC bioscience), 275 μg ml−1 Human holo-
transferrin (Sigma Aldrich), 20 ng ml−1 bFGF (Stemgent), 50 ng ml−1 Human VEGF-165 aa 
(Humanzyme), 25 ng ml−1 human BMP4 (Stemgent), 450 μM monothioglycerol (Sigma 
Aldrich), 2.25 mM each L-Glutamine and Non-essential amino acids (Invitrogen), 
systematically designed by titration of growth factors and culture conditions. Media was 
changed every second day with addition of half the volume of media every other day.
Single Cell Differentiation Assays
Upon MIM differentiation for 8 days, CD34+ Angioblast-like cells (Angioblast-like) were 
sorted and plated in collagen I coated 48-well plates at a density of one cell/well in either 
EBM-2 (endothelial differentiation) or SmBM (Smooth Muscle differentiation) 
supplemented as described above. After 7 days in the respective differentiation conditions 
cells were washed once with PBS and fixed with 4% Paraformaldehyde (PFA) in 1X PBS. 
Following fixation, cells were blocked and permeabilized for 1 hour at 37° C with 5% 
BSA/5% appropriate serum/1X PBS in the presence of 0.1% Triton X100. Subsequently, 
cells were incubated overnight at 4° C with an anti-endoglin antibody in case of cells in 
EBM-2/EGM-2 or with an anti-calponin antibody in the case of cells in SmBM/SmGM-2. 
Cells were then washed thrice with 1X PBS, incubated for 1 hour at 37° C with the 
respective secondary antibodies and 20 minutes with DAPI for nuclear staining. Following 
incubation, cells were washed thrice with 1X PBS before microscopy analysis and scoring.
Conversion of human fibroblasts into angioblast-like CD34+ progenitor cells
For retroviral infection, 75,000/well human fibroblast cells (HFF-1, BJ, HFF-693) were 
plated on matrigel-coated 6-well plates. The next day, cells were infected with an equal ratio 
of either a combination of 4 pMX-derived retroviruses encoding Oct4, SOX2, KLF4 and c-
Myc (4F) or 5 pMX-derived retroviruses encoding Oct4, SOX2, KLF4, c-Myc and miRs302–
367 (4F/miRs). Scramble miRNA control (PMIRH000PA-1, SBI) was used whenever 
appropriate. The plates were infected by spinfection of the cells at 1850 rpm for 1 hour at 
room temperature in the presence of polybrene (4 μg ml−1) and put back in the incubator 
without media change. 24 hours later, the media was switched to WiCell media composed of 
DMEM/F12 (Invitrogen), 20% Knockout serum replacement, 10 ng ml−1 bFGF, 1 mM 
GlutaMax, 0.1 mM non-essential amino acids and 55 μM β-mercaptoethanol; with media 
changes every day. After 6 days, cells were split at a ratio of 1:3 on to matrigel coated 6-
well plates supplemented with WiCell media for another 2 days. The cells were then washed 
once with DMEM/F12 and induced for differentiation for 8 days in the presence of MIM. 
Media was changed every second day with addition of half the volume of media every other 
day.
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For episomal transfection, 2.106 cells were transfected with 1.5μg each of pCXLE-episomal 
vectors encoding for Oct4, SOX2, KLF4, LMYC, LIN28 and shRNA-p5322 (#27077, #27078 
and #27080, addgene) with and without addition of pcDNA3.1 encoding for miRs302–367 
(6F or 6F/miRs). Fibroblasts were transfected by nucleofection (Amaxa NHDF nucleofector 
kit, # VPD-1001) according to manufacturer’s instructions, and plated back on to matrigel-
coated wells. After 6 days resting in DMEM/F12 supplemented with 10% FBS, 0.1 mM 
non-essential amino acids and 2 mM GlutaMAX, the media was switched to WiCell media 
with media changes every day. After 6 days, cells were split at a ratio of 1:3 on to matrigel 
coated 6-well plates with WiCell media for another 2 days. The cells were then washed once 
with DMEM:F12 and induced for differentiation for 8 days in the presence of MIM. Media 
was changed every second day with addition of half the volume of media every other day.
RNA isolation and real time-PCR analysis
Total cellular RNA was isolated using Trizol Reagent (Invitrogen) according to the 
manufacturer’s recommendations. 2μg of DNAse1 (Invitrogen) treated total RNA was used 
for cDNA synthesis using the SuperScript II Reverse Transcriptase kit for RT-PCR 
(Invitrogen). Real-time PCR was performed using the SYBR-Green PCR Master mix 
(Applied Biosystems). The levels of expression of respective genes were normalized to 
corresponding GAPDH values and are shown as fold change relative to the value of the 
control sample. All the samples were done in triplicate. The list of the primers used for real 
time-PCR experiments are listed in Supplementary Table 3.
Flow cytometry analysis
Human ES/iPS cells undergoing directed differentiation, lineage converted CD34+ cells or 
their respectively derived endothelial cells were harvested using TripLE (Invitrogen), 
washed once with PBS and further incubated with the corresponding antibodies in the 
presence of FACS blocking buffer (1xPBS/10%FCS) for 1 hour on ice in the absence of 
light. After incubation, cells were washed thrice with 1 ml of FACS blocking buffer and 
resuspended in a total volume of 200 μl prior to analysis. A minimum of 10,000 cells in the 
living population were analyzed by using a BD LSRII flow cytometry machine equipped 
with 5 different lasers and the BD FACSDiva software. Percentages are presented after 
subtracting isotype background and referring to the total living population analyzed. Results 
are representative of at least three independent experiments with a minimum of two 
technical replicates per experiment.
Cell sorting
After 8 days of differentiation CD34+ cells were stained as described above and sorted by 
using a BDAria II FACS sorter (BD Biosystems). Alternatively, CD34+ cells were enriched 
using anti-CD34 conjugated magnetic beads (Miltenyi) according to the manufacturer’s 
instructions with slight modifications. Briefly, up to 109 cells were incubated with constant 
mixing at 4°C with 100 μl of the corresponding magnetic beads in the presence of 100 μl of 
Fc-blocking solution in a total volume of 500 μl FACS blocking buffer. After 1 hour, cells 
were sorted by two consecutive rounds of column separation in order to increase purity by 
applying MACS separation magnets. Shortly, cells were passed through the first MS 
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separation column allowing binding of labeled cells. Non-labeled cells were washed 
thoroughly with 3 ml FACS blocking buffer prior to elution of the labeled fraction. Eluted 
labeled cells were then subjected to a second purification step as described above.
Differentiation of CD34+ cells to endothelial cells
PSC- and lineage converted-CD34+ cells, isolated by MACS or by FACS sorting after 8 
days of differentiation in MIM, were plated in collagen I coated plates (50,000 cells well−1 
of a 12 well plate) and cultured in EBM-2/EGM-2 (Lonza) with media changes every day. 
After 5–8 days in culture, upon reaching 90% confluence, cells were split 1:4, using TripLE 
(Invitrogen). The cells were cultured for at least 8 passages.
Differentiation of CD34+ cells to smooth muscle cells
PSC- and lineage converted-CD34+ cells, isolated by MACS or by FACS sorting after 8 
days of differentiation in MIM, were plated in collagen I coated plates (50,000 cells well−1 
of a 12-well plate) and cultured in SmBM/SmGM-2 (Lonza) with media changes every day. 
After 5–8 days in culture, upon reaching 90% confluence, cells were split 1:4, using TripLE 
(Invitrogen). The cells were cultured for at least 8 passages.
DNA Methylation Analysis
Illumina 450K Infinium Methylation Arrays were normalized and pre-processed in Genome 
Studio. Probes with missing values were removed. A filter for average Beta value difference 
between groups (PSCs, Fibroblasts, primary human Arterial Smooth Muscle Cells 
(PriSMC), primary human Umbilical Vein Endothelial Cells (PriEC), PSC → CD34+ 
Progenitor Cells, PSC → Endothelial Cells (iECs), converted Endothelial Cells (cECs), PSC 
→ Smooth Muscle Cells (iSMCs), converted Smooth Muscle Cells (cSMCs)) of ≥0.3 was 
applied. The resulting probes were used for ANOVA analysis using R scripts with a p-value 
filter of <0.0001)(at this point, 30,000 probes remained). Probes with beta value difference 
of at least 0.3 ((max - min) >= 0.3) were used. ANOVA test (p<0.05; Var 0.58) was applied 
to obtain statistically significant differentially methylated probes among the 5 groups in both 
SMC and EC sample group. The resulting probes (see Supplementary Data) were used for 
hierarchical clustering using Cluster 3.0 with complete linkage. Venn Diagram Plotter 
(http://omics.pnl.gov/software/VennDiagramPlotter.php) was used to generate “area-
proportional Venn Diagrams”.
Gene Expression microarray analysis
The following groups were analyzed: PSCs, Fibroblasts, primary human Arterial Smooth 
Muscle Cells (PriSMC), primary human Umbilical Vein Endothelial Cells (PriEC), PSC → 
Endothelial Cells (iECs), converted Endothelial Cells (cECs), PSC → Smooth Muscle Cells 
(iSMCs) and converted Smooth Muscle Cells (cSMCs). Briefly, total RNA was extracted 
from collected sample pellets (Ambion mirVana; Applied Biosystems) according to the 
manufacturer’s protocol. RNA quantity (Qubit™ RNA BR Assay Kits; Invitrogen) and 
quality (RNA6000 Nano Kit; Agilent) was determined to be optimal for each sample prior to 
further processing. 200ng RNA per sample was amplified using the Illumina® Total Prep™ 
RNA Amplification Kit according to manufacturer’s protocol and quantified as above. 
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750ng RNA/sample was hybridized to Illumina HT-12v3 Expression BeadChips, scanned 
with an Illumina iScan Bead Array Scanner and quality controlled in GenomeStudio and the 
lumi bioconductor package. All RNA processing and microarray hybridizations were 
performed in-house according to manufacturer’s protocols. Differential expression was 
defined as a minimum 2x fold-change and multiple-testing corrected p<0.05 by ANOVA. 
The resulting probes (see Supplementary Data) were used for hierarchical clustering using 
Cluster 3.0 with complete linkage. Probes with minimum gene expression differences 
between groups of 2× fold-change were obtained (see Supplementary Data). Venn Diagram 
Plotter (http://omics.pnl.gov/software/VennDiagramPlotter.php) was used to generate “area-
proportional Venn Diagrams”.
Determination of copy number by quantitative PCR
Briefly, total DNA was extracted using the Qiagen DNeasy Blood & Tissue kit (QIAGEN). 
The purity and quantity of DNA was measured using a NanoDrop 8000 spectrophotometer 
(Thermo Scientific), and then used as templates for absolute quantitation by qPCR assay22. 
The primers used are listed above and their amplification efficiencies, as well as specificity, 
were checked by performing standard curve and melting curve analyses.
Immunocytochemistry and fluorescence Microscopy
Briefly, cells were washed thrice with PBS and fixed using 4% PFA in 1X PBS. After 
fixation, cells were blocked and permeabilized for 1 hour at 37° C with 5% BSA/5% 
appropriate serum/1X PBS in the presence of 0.1% Triton X100. Subsequently, cells were 
incubated with the indicated primary antibody either for 1 hour at room temperature or 
overnight at 4° C. The cells were then washed thrice with 1X PBS and incubated for 1 hour 
at 37° C with the respective secondary antibodies and 20 minutes with DAPI or Hoechst 
33342. Cells were washed thrice with 1X PBS before analysis. Sections were analyzed by 
using an Olympus 1X51 upright microscope equipped with epifluorescence and TRITC, 
FITC, and DAPI filters. Confocal image acquisition was performed using a Zeiss LSM 780 
laser scanning microscope (Carl Zeiss Jena, Germany) with 20×, 40× or 63× immersion 
objectives.
Acetylated-LDL uptake assay and vascular tube-like structure formation assay
In short, 80% confluent endothelial cells derived from human ES/iPS cells were incubated 
with 10μg ml−1 Dil-Ac-LDL (L23380, Molecular Probes) for 3 hours in DMEM:F12. The 
cells were washed 3 times with PBS, dissociated using TripLE and analyzed by flow 
cytometry. Briefly, to assess the formation of capillary structures, a suspension of 4.105 cells 
ml−1 endothelial cells in the presence EBM-2/EGM-2 was prepared. Subsequently, 100 μl 
well−1 were dispensed on flat bottom 96 well plates coated with Matrigel (BD biosciences). 
Tube formation was observed after 24 hours of incubation and a minimum of three 
replicates per experiment analyzed.
Hematopoietic colony-forming assays
Hematopoietic clonogenic assays were performed in 35-mm low adherent plastic dishes 
(Stem Cell Technologies, Vancouver, BC, Canada) using 1.1 ml dish−1 of methylcellulose 
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semisolid medium (MethoCult H4434 classic, Stem Cell Technologies) according to the 
manufacturer’s instructions. Briefly, enriched CD34+ cells were sorted and immediately 
plated at various densities: 1.5 × 103 ml−1, 3 × 103 ml−1 and 6 × 103 ml−1. All assays were 
performed in duplicate. After 21 days of incubation plates were analyzed for the presence of 
both, Colony-forming units (CFU) and Burst-forming units (BFU).
Animals
All murine experiments were conducted with approval of The Salk Institute Institutional 
Animal Care and Use Committee (IACUC). NOD.Cg-PrkdcscidIl2rgtm1Wjl/SzJ mice (or 
NOD-Scid IL2rγ null abbreviated as NSG; age, 7 weeks; weight, 20 g) were purchased from 
Charles River Laboratories, housed in air-flow racks on a restricted access area and 
maintained on a 12 hour light/dark cycle at a constant temperature (22 ±1°C).
Matrigel plug assay
Anaesthesia was induced using a mixture of Xylazine (Rompun® 2%, Bayer) at 10 mg kg−1 
and Ketamine (Imalgene1000, Merial) at 100 mg kg−1 in NaCl at 0.9% i.p injected at a dose 
of 10 ml kg−1. The animals’ backs were shaved, swabbed with Hexomedine®. Prior 
injection, HUVECs, HUES9-, KiPS-, BJ 6F- and BJ 6F/miRs- derived endothelial cells were 
harvested using TripLE (invitrogen). A total of 1.106 cells were resuspended in 500 μl of 
cold matrigel (Matrigel basement membrane matrix from BD Biosciences adjusted to 9.8 mg 
ml−1 PBS) supplemented with 150 ng of bFGF. Cell and no cell containing matrigel 
solutions were then injected subcutaneously in the back of mice, carefully positioning the 
needle between the epidermis and the muscle layer. Seventeen days later, mice were 
sacrificed and the matrigel plugs were removed by a wide excision of the back skin, 
including the connective tissues (skin and all muscle layers).
Tissue processing/analyses
For immunohistochemistry (IHC), in situ hybridization (ISH) or immunofluorescence (IF) 
analysis, cell-containing implants with associated connective tissues were fixed with 
Accustain® (SIGMA) for 24 hours, dehydrated through an ethanol series and then processed 
for paraffin embedding before being sliced with a microtome. Slices from paraffin-
embedded samples were stained with appropriate antibodies or probes. Alternatively, plugs 
were harvested and fixed with a 4% paraformaldehyde solution overnight at 4°, washed 
thrice in PBS and then incubated in a glucose solution (30%) for another 48 hours before 
being sliced (45μm) with a cryostat (Leica). Both methodologies were equally successful to 
identify neovasculature derived from human cells.
For IHC, slides were stained with an anti human-CD31 monoclonal antibody and then 
incubated with biotin-labeled secondary antibody followed by incubation with streptavidin-
HRP (Ventana Roche).
For ISH, slides were hybridized according to the manufacturer’s protocol with an Alu probe 
(780–2845, Ventana Roche) and then labeled with the ISH iView Blue Detection kit (760–
092, Ventana Roche).
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For IHC and ISH, images were then captured with a camera mounted on a light microscope 
(Nikon E-800).
For immunofluorescence assays, slides were stained with either rhodamine-labeled Ulex 
Europaeus Agglutinin I (UEA I, a marker for human endothelial cells from Vector 
Laboratories) or PECAM-1 (M-20) (CD31; sc1506, Santa Cruz Biotechnology) and anti-
Human Nuclei 1:100 (MAB1281, Millipore) counterstained with DAPI. Images were 
captured with confocal microscopes (Zeiss, LSM 510 or LSM780).
Calcium live cell imaging
Subconfluent cells were washed with DMEM:F12 and incubated for 45 minutes with 1 μM 
Fluo-4/AM (Molecular Probes) in 0.5% BSA, DMEM:F12 in an incubator at 37 °C, 95% 
CO2. After washing to remove unloaded dye, cells responses to 100 μM carbachol or vehicle 
(water) were imaged in HEPES-buffered, phenol red-free DMEM:F12 in a wide field 
fluorescent microscope (Olympus BX61WI) equipped for fast fluorescent imaging. Image 
capture was performed with Metamorph and an EM-CCD camera (Hamamatsu). Image 
analysis was carried out with Metamorph and Fiji software. To determine functional SMC 
contraction after stimulations, the cell surface area was determined before and after 
carbachol exposure.
Statistical evaluation
Statistical analyses of all endpoints were performed by using standard unpaired Student t test 
(one-tailed, 95% confidence intervals) using the SPSS/PC + statistics 11.0 software (SPSS 
Inc.). All data are presented as mean ± standard deviation (s.d.) or standard error of the 
mean (s.e.m.) where indicated and represent a minimum of two independent experiments 
with at least two technical duplicates.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Differentiation of hPSCs into mesodermal progenitor and terminally differentiated 
endothelial cells
a) Scheme and Representative bright field pictures during the course of differentiation of 
human pluripotent stem cells towards CD34+ progenitor cells. b–e) Flow cytometry analysis 
of the mesoderm markers CD34 and CD31 over the differentiation course on HuES9 
embryonic stem cells (b), H1 embryonic stem cells (c), two-factor cord blood-derived iPS 
cells (CBiPS) (d) and four factor keratinocyte-derived iPS (KiPS) (e). Representative flow 
cytometry plots depicting a double CD34+CD31+ population obtained after 8 days of PSC 
differentiation in the presence of Mesodermal Induction Media (MIM). Upper panel shows 
isotype controls. Lower panel shows specific CD34 and CD31 staining (f). g) mRNA fold-
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change of pluripotency and mesodermal markers on KiPS. h) Fluorescence microscopy 
analysis showing the expression of indicated endothelial cell markers in KiPS derived 
Endothelial Cells (KiPSEndo). i) mRNA expression profile showing specific upregulation of 
endothelial markers in KiPSEndo. j–k) Heat-map and representative clustering of hPSCs as 
compared to induced/differentiated endothelial (iECs) as well as a representative primary 
endothelial cell line (Human Umbilical Vein Endothelial Cells; HUVEC). On the left, 
genome-wide transcriptome analysis results demonstrate high similarities between PSC-
differentiated and primary endothelial cells (j). On the right, genome-wide methylation 
profiling representing the epigenetic changes occurring upon differentiation of PSCs into 
endothelial cells (iECs). Generated endothelial cells cluster closely to primary endothelial 
cells (k). See Supplementary Table 2 for specific gene-expression changes as summarized in 
the main figure panels. Error bars, s.d. Scale bars: 200 μm (a), 50μm (h). Endoglin and VE-
cadherin stainings are depicted in green; vWF stainings are depicted in magenta; Nuclear 
stainings are depicted in blue.
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Figure 2. Conversion of human fibroblasts into mesodermal progenitor and terminally 
differentiated endothelial cells by retroviral approaches
a) Schematic representation of the conversion process towards CD34+ progenitor cells and 
further differentiation into terminally differentiated endothelial cells. b) Representative flow 
cytometry plots demonstrating absent expression of pluripotency-associated markers upon 
plastic induction followed by Mesodermal Induction Media (MIM) differentiation. c) Flow 
cytometry analysis of CD34 expression after MIM induction in neonatal human fibroblasts 
in the presence of miR302-367 or the respective scramble controls. d) mRNA expression 
profiling of mesodermal genes upon the first phase of “plastic induction” (left panels); 
mRNA expression profiling of mesodermal genes upon “plastic induction” followed by 
MIM differentiation (right panels). Note the significant upregulation of all mesodermal and 
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angioblast-related markers upon MIM exposure. e) mRNA expression profile showing 
specific upregulation of Endothelial Cell (EC) markers upon specific differentiation of 
sorted FibCD34+ cells into “converted” ECs. f) Fluorescence microscopy analysis showing 
the expression of the indicated endothelial markers in converted cells. g–h) Heat-map and 
representative clustering of the initial fibroblasts population as compare to 
converted FibCD34+ cells, endothelial cells (cECs) and a representative primary endothelial 
cell line (Human Umbilical Vein Endothelial Cells; HUVEC). On the left, genome-wide 
transcriptome analysis results demonstrating high similarities between converted and 
primary endothelial cells (g). On the right, genome-wide methylation profiling representing 
the epigenetic changes occurring upon conversion into converted endothelial cells. 
Converted endothelial cells (cECs) cluster closely to primary endothelial cells (h). See 
Supplementary Table 2 for specific gene-expression changes as summarized in the main 
figure panels. Scale bars: 50μm (f). Error bars, s.d. *P<0.05. Endoglin and VE-cadherin 
stainings are depicted in green; vWF stainings are depicted in magenta; Nuclear stainings 
are depicted in blue.
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Figure 3. Conversion of human fibroblasts into mesodermal progenitor and terminally 
differentiated endothelial cells by non-integrative approaches
a) Schematic representation of the conversion process towards CD34+ progenitor cells and 
further differentiation into terminally differentiated endothelial cells. b) Representative flow 
cytometry plots demonstrating absent expression of pluripotency-associated markers upon 
plastic induction with non-integrative plasmids followed by Mesodermal Induction Media 
(MIM) differentiation. c) Representative flow cytometry analysis of CD34 expression before 
and after MIM differentiation in human fibroblasts (BJ) induced to a plastic state by the use 
of non-integrative approaches in the presence of miR302-367 or respective scramble 
controls. Upper panel shows isotype controls. Lower panel shows specific CD34. d) 
Representative flow cytometry quantification of BJ-converted VE-cadherin+ and endoglin+ 
endothelial cells derived in the presence of miR302/367 or respective scramble controls. e) 
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mRNA expression profile showing specific upregulation of endothelial markers upon 
specific differentiation of sorted BJ FibCD34+ cells into “converted” endothelial cells. f) 
Fluorescence microscopy analysis showing the expression of the indicated endothelial 
markers in converted cells. g) Characterization of endothelial subtypes in BJ converted 
endothelial cells. Note the mixed expression of different endothelial subtype markers 
including arterial, venous and lymphatic upon conversion of fibroblasts. h) Representative 
pictures of endothelial cells derived by non-integrative approaches upon LDL uptake as 
compared to the respective controls (upper panels). LDL Mean Fluorescence Intensities of 
BJ-derived endothelial cells that were converted by non-integrative approaches (lower 
panels). Controls represent converted endothelial cells in the presence of Alexa Fluor 488 in 
order to measure unspecific fluorescence background. i) BJ-derived endothelial cells 
converted by non-integrative approaches spontaneously formed capillary-like structures in 
vitro. See Supplementary Table 2 for specific gene-expression changes as summarized in the 
main figure panels. Scale bars: 50 μm (f); 100μm (h); 200μm (i). Error bars, s.d. *P<0.05. 
Endoglin and VE-cadherin stainings are depicted in green; vWF stainings are depicted in 
magenta; Nuclear stainings are depicted in blue.
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Figure 4. Generated Endothelial cells demonstrate functionality in vivo
a) 17 days after injection, matrigel plugs were extracted and processed for analyses. Pictures 
show increased blood circulation through the extracted plugs, thus demonstrating connection 
with the pre-existing vasculature (anastomosis) in vivo. b, c) Representative pictures of 
HuES9- (left panels) and KiPS- (right) derived endothelial cells showing the identification 
of human cells by in situ hybridization on ALU+ sequences (dark blue dot), anti-human 
CD31 staining (brown) and Ulex Lectin rhodamine staining (red). Note the presence of 
circulating red blood cells through the vessel-graft. d) Endothelial cells derived by non-
integrative approaches-mediated conversion of human fibroblasts demonstrate anastomosis 
in vivo. Human specific CD31 antibody demonstrates the presence of converted endothelial 
cells (green). Co-localization with specific Human Nuclear Antigen staining demonstrates 
that the generated vessels are derived from the injected converted human endothelial cells. 
e) Representative high magnification picture demonstrating connection to the pre-existing 
vasculature upon injection of converted endothelial cells generated by non-integrative 
approaches. White arrows indicate the presence of circulating red blood cells. Scale bars: 5 
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μm (b, c); 50μm (d, e). CD31 stainings are depicted in green; Human Nuclear Antigen 
(HuNu) stainings are depicted in magenta; Nuclear stainings are depicted in blue.
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